These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17428181)

  • 1. ChREBP, a transcriptional regulator of glucose and lipid metabolism.
    Postic C; Dentin R; Denechaud PD; Girard J
    Annu Rev Nutr; 2007; 27():179-92. PubMed ID: 17428181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ChREBP in hepatic steatosis and insulin resistance.
    Denechaud PD; Dentin R; Girard J; Postic C
    FEBS Lett; 2008 Jan; 582(1):68-73. PubMed ID: 17716660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of carbohydrate-activated transcription factor ChREBP prevents obesity and improves plasma glucose control in leptin-deficient (ob/ob) mice.
    Iizuka K; Miller B; Uyeda K
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E358-64. PubMed ID: 16705063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-regulation of hepatic glucose metabolism via ChREBP and nuclear receptors.
    Poupeau A; Postic C
    Biochim Biophys Acta; 2011 Aug; 1812(8):995-1006. PubMed ID: 21453770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary Macronutrient Composition Directs ChREBP Isoform Expression and Glucose Metabolism in Mice.
    Jois T; Howard V; Youngs K; Cowley MA; Sleeman MW
    PLoS One; 2016; 11(12):e0168797. PubMed ID: 27992582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Can the hyperactivity of lipogenesis cause hepatic steatosis? A role for ChREBP].
    Robichon C; Girard J; Postic C
    Med Sci (Paris); 2008 Oct; 24(10):841-6. PubMed ID: 18950580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis.
    Uyeda K; Repa JJ
    Cell Metab; 2006 Aug; 4(2):107-10. PubMed ID: 16890538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
    Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
    Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress on the role of ChREBP in glucose and lipid metabolism.
    Iizuka K
    Endocr J; 2013; 60(5):543-55. PubMed ID: 23604004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
    Ferré P; Foufelle F
    Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The transcription factor ChREBP: a key modulator of insulin sensitivity?].
    Benhamed F; Poupeau A; Postic C
    Med Sci (Paris); 2013; 29(8-9):765-71. PubMed ID: 24005632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel aminosterol reverses diabetes and fatty liver disease in obese mice.
    Takahashi N; Qi Y; Patel HR; Ahima RS
    J Hepatol; 2004 Sep; 41(3):391-8. PubMed ID: 15336441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription.
    Ishii S; Iizuka K; Miller BC; Uyeda K
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15597-602. PubMed ID: 15496471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate responsive element binding protein and lipid homeostasis.
    Denechaud PD; Girard J; Postic C
    Curr Opin Lipidol; 2008 Jun; 19(3):301-6. PubMed ID: 18460923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice.
    Bijl N; Sokolović M; Vrins C; Langeveld M; Moerland PD; Ottenhoff R; van Roomen CP; Claessen N; Boot RG; Aten J; Groen AK; Aerts JM; van Eijk M
    Hepatology; 2009 Nov; 50(5):1431-41. PubMed ID: 19731235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic miR-378 targets p110α and controls glucose and lipid homeostasis by modulating hepatic insulin signalling.
    Liu W; Cao H; Ye C; Chang C; Lu M; Jing Y; Zhang D; Yao X; Duan Z; Xia H; Wang YC; Jiang J; Liu MF; Yan J; Ying H
    Nat Commun; 2014 Dec; 5():5684. PubMed ID: 25471065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice.
    Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT
    Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulation of carbohydrate metabolism by insulin: role of transcription factor SREBP-1c in the hepatic transcriptional effects of the hormone].
    Foufelle F; Ferré P
    J Soc Biol; 2001; 195(3):243-8. PubMed ID: 11833461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.